Dr. Kelley's studies have included examinations of longitudinal changes in bone and body composition in obese adolescents undergoing weight loss as well as in newly diagnosed children with type 1 diabetes. She has also conducted studies evaluating lipid abnormalities in high risk pediatric populations. Dr. Kelley's clinical and research interests within lipidology include familial hypercholesterolemia, hypertriglyceridemia and abnormal lipoprotein(a) in children. She is currently a local principal investigator for clinical trials, including use of PCSK-9 inhibitors in children with familial hypercholesterolemia. She also is a local principal investigator in the Type 1 Diabetes Exchange, a multi-institutional collaboration to improve the lives and care of patients with type 1 diabetes.